International Clinical Trial: Efficacy and Safety of Avatrombopag for Thrombocytopenia After Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized, Open-Label, Active-Controlled Study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131683) titled 'Efficacy and Safety of Avatrombopag for Thrombocytopenia After Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective, Randomized, Open-Label, Active-Controlled Study' on Sept. 5.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Qilu Hospital of Shandong University

Condition: Haploidentical hematopoietic stem cell transplantation

Intervention: A group: Avacopan + routine treatment:A group received avacopan + routine treatment B group: Romiplostim + routine treatment:B group received romiplostim + routine treatment

Recruitment Status: Not Recruiting

Phase: N/A

D...